Clinical Trial Update: CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing CpG 7909 in patients who have undergone autologous stem cell transplant has been terminated. The study included patients with germ cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Germ Cell Tumor
• Leukemia
• Lymphoma
• Multiple Myeloma

Drugs mentioned

• CPG 7909 (CpG 7909)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Germ Cell Tumor, Leukemia | Phase 1 | Status: TERMINATED